Article
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Leukemia - 1 Feb 2023
Mansouri Larry, Thorvaldsdottir Birna, Sutton Lesley-Ann, Karakatsoulis Georgios, Meggendorfer Manja, Parker Helen, Nadeu Ferran, Brieghel Christian, Laidou Stamatia, Moia Riccardo, Rossi Davide, Catherwood Mark, Kotaskova Jana, Delgado Julio, Rodríguez-Vicente Ana E, Benito Rocío, Rigolin Gian Matteo, Bonfiglio Silvia, Scarfo Lydia, Mattsson Mattias, Davis Zadie, Gogia Ajay, Rani Lata, Baliakas Panagiotis, Foroughi-Asl Hassan, Jylhä Cecilia, Skaftason Aron, Rapado Inmaculada, Miras Fatima, Martinez-Lopez Joaquín, de la Serna Javier, Rivas Jesús María Hernández, Thornton Patrick, Larráyoz María José, Calasanz María José, Fésüs Viktória, Mátrai Zoltán, Bödör Csaba, Smedby Karin E, Espinet Blanca, Puiggros Anna, Gupta Ritu, Bullinger Lars, Bosch Francesc, Tazón-Vega Bárbara, Baran-Marszak Fanny, Oscier David, Nguyen-Khac Florence, Zenz Thorsten, Terol Maria Jose, Cuneo Antonio, Hernández-Sánchez María, Pospisilova Sarka, Mills Ken, Gaidano Gianluca, Niemann Carsten U, Campo Elias, Strefford Jonathan C, Ghia Paolo, Stamatopoulos Kostas, Rosenquist Richard
Abstract excerpt
Recent evidence suggests that the prognostic impact of gene mutations in patients with chronic lymphocytic leukemia (CLL) may differ depending on the immunoglobulin heavy variable (IGHV) gene somatic hypermutation (SHM) status. In this study, we assessed the impact of nine recurrently mutated genes (BIRC3, EGR2, MYD88, NFKBIE, NOTCH1, POT1, SF3B1, TP53, and XPO1) in pre-treatment samples from 4580 patients with...
Read the complete abstract on PubMed